SG170009A1 - Polypeptide markers for the diagnosis and evaluation of vascular diseases - Google Patents
Polypeptide markers for the diagnosis and evaluation of vascular diseasesInfo
- Publication number
- SG170009A1 SG170009A1 SG201101212-7A SG2011012127A SG170009A1 SG 170009 A1 SG170009 A1 SG 170009A1 SG 2011012127 A SG2011012127 A SG 2011012127A SG 170009 A1 SG170009 A1 SG 170009A1
- Authority
- SG
- Singapore
- Prior art keywords
- vascular diseases
- diagnosis
- evaluation
- polypeptide markers
- markers
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6848—Methods of protein analysis involving mass spectrometry
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/493—Physical analysis of biological material of liquid biological material urine
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- Hematology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Electrochemistry (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102005057382 | 2005-11-30 | ||
| EP06120879 | 2006-09-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG170009A1 true SG170009A1 (en) | 2011-04-29 |
Family
ID=38092603
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG201101212-7A SG170009A1 (en) | 2005-11-30 | 2006-11-30 | Polypeptide markers for the diagnosis and evaluation of vascular diseases |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US20100126861A1 (ru) |
| EP (1) | EP1955075A2 (ru) |
| JP (1) | JP5165580B2 (ru) |
| KR (1) | KR20080074190A (ru) |
| AU (1) | AU2006319138B2 (ru) |
| BR (1) | BRPI0619248A2 (ru) |
| CA (1) | CA2631602A1 (ru) |
| EA (1) | EA014529B1 (ru) |
| IL (1) | IL191605A0 (ru) |
| NO (1) | NO20082394L (ru) |
| SG (1) | SG170009A1 (ru) |
| WO (1) | WO2007063089A2 (ru) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011029954A2 (de) * | 2009-09-14 | 2011-03-17 | Mosaiques Diagnostics And Therapeutics Ag | Polypeptidmarker zur diagnostik und beurteilung vaskulärer erkrankungen |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0206903B8 (pt) * | 2002-12-20 | 2021-07-27 | Fund De Amparo A Pesquisa Do Estado De Sao Paulo Fapesp | método de prognóstico de uma predisposição para o desenvolvimento de hipertensão e lesões no coração, sistema nervoso, sistema vascular ou rins, e uso da isoforma de 90 kda da enzima conversora de angiotensina i no referido método |
| WO2004089184A2 (en) * | 2003-04-01 | 2004-10-21 | Diadexus, Inc. | NEW USES OF Lp-PLA2 IN COMBINATION TO ASSESS CORONARY RISK |
| US7344892B2 (en) * | 2003-09-23 | 2008-03-18 | Beth Israel Deaconess Medical Center, Inc. | Screening for gestational disorders |
-
2006
- 2006-11-30 KR KR1020087015342A patent/KR20080074190A/ko not_active Application Discontinuation
- 2006-11-30 BR BRPI0619248-3A patent/BRPI0619248A2/pt not_active IP Right Cessation
- 2006-11-30 EP EP06819861A patent/EP1955075A2/de not_active Ceased
- 2006-11-30 US US12/085,633 patent/US20100126861A1/en not_active Abandoned
- 2006-11-30 WO PCT/EP2006/069096 patent/WO2007063089A2/de active Application Filing
- 2006-11-30 AU AU2006319138A patent/AU2006319138B2/en not_active Ceased
- 2006-11-30 EA EA200801475A patent/EA014529B1/ru not_active IP Right Cessation
- 2006-11-30 CA CA002631602A patent/CA2631602A1/en not_active Abandoned
- 2006-11-30 JP JP2008542758A patent/JP5165580B2/ja not_active Expired - Fee Related
- 2006-11-30 SG SG201101212-7A patent/SG170009A1/en unknown
-
2008
- 2008-05-21 IL IL191605A patent/IL191605A0/en unknown
- 2008-05-27 NO NO20082394A patent/NO20082394L/no not_active Application Discontinuation
-
2015
- 2015-05-14 US US14/712,423 patent/US20150247865A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EA200801475A1 (ru) | 2009-02-27 |
| WO2007063089A3 (de) | 2008-01-17 |
| WO2007063089A2 (de) | 2007-06-07 |
| EA014529B1 (ru) | 2010-12-30 |
| NO20082394L (no) | 2008-08-26 |
| KR20080074190A (ko) | 2008-08-12 |
| CA2631602A1 (en) | 2007-06-07 |
| EP1955075A2 (de) | 2008-08-13 |
| AU2006319138B2 (en) | 2013-05-16 |
| IL191605A0 (en) | 2008-12-29 |
| JP2009521670A (ja) | 2009-06-04 |
| US20100126861A1 (en) | 2010-05-27 |
| US20150247865A1 (en) | 2015-09-03 |
| AU2006319138A1 (en) | 2007-06-07 |
| BRPI0619248A2 (pt) | 2011-09-20 |
| JP5165580B2 (ja) | 2013-03-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW200636076A (en) | Method for measuring resistance or sensitivity to docetaxel | |
| WO2006134390A3 (en) | Method for diagnosing neurodegenerative disease | |
| ATE310955T1 (de) | Zusammensetzungen und verfahren zum nachweis und zur behandlung von mit chemokinrezeptoren verbundenen krankheiten | |
| KR100711046B1 (ko) | 대장암에 대한 마커로서의 니코틴아미드ｎ―메틸트랜스퍼라아제의 용도 | |
| DE602006019128D1 (de) | Moesin, caveolin 1 und yes-assoziiertes protein 1 als prädiktive marker der reaktion auf dasatinib bei brustkrebs | |
| DK1421215T3 (da) | Fremgangsmåder til evaluering af patologiske tilstande under anvendelse af ekstracellulært RNA | |
| WO2004055519A3 (en) | Specific markers for pancreatic cancer | |
| EP2021794B8 (en) | Use of protein s100a 12 as a marker for colorectal cancer | |
| WO2005098433A3 (en) | Diagnostic assays for alzheimer’s disease | |
| DE602004016499D1 (de) | Zusammensetzungen und verfahren zur behandlung von entzündlicher darmerkrankung | |
| WO2010079076A3 (de) | Autosomal dominante polyzystische nierenerkrankung (adpkd) | |
| DE60325382D1 (de) | Verfahren zur diagnose von gebärmutterhalskrebs | |
| WO2011029954A3 (de) | Polypeptidmarker zur diagnostik und beurteilung vaskulärer erkrankungen | |
| WO2006106129A3 (de) | Polypeptidmarker zur diagnose von prostatakrebs | |
| ATE406579T1 (de) | Verfahren zur diagnose von tumoren | |
| WO2008116178A3 (en) | Systems and methods for diagnosis and prognosis of colorectal cancer | |
| DE60331857D1 (de) | Markerproteine zur diagnose einer lebererkrankung und verfahren zur diagnose einer lebererkrankung damit | |
| WO2009047280A3 (de) | Polypeptidmarker zur diagnose von prostatakrebs | |
| WO2006066917A3 (en) | Use of asc as a marker for colorectal cancer | |
| DE602004017317D1 (de) | Verwendung der proteine proteinase 3 (prn3) und leukozyten elastatse inhibitor (ileu) als marker für kolorektale karzinome | |
| SG170009A1 (en) | Polypeptide markers for the diagnosis and evaluation of vascular diseases | |
| WO2009019366A3 (fr) | Procede de dosage de l'aminoacylase 1 pour le diagnostic in vitro du cancer colorectal | |
| ATE534037T1 (de) | Verwendung des proteins asc als marker für brustkrebs | |
| ATE353544T1 (de) | Verwendung des proteins masp als marker für kolorektale karzinome | |
| ATE432469T1 (de) | Auf immunreaktion gegen boris basierendes verfahren für den nachweis von krebs |